Abhisek Swaika

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma

Asher Chanan‐Khan, Abhisek Swaika, Aneel Paulus et al. · Blood Cancer Journal · 2013 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a <scp>SEER</scp>‐medicare analysis

Sikander Ailawadhi, Ryan D. Frank, Pooja Advani et al. · Cancer Medicine · 2017 · 88 citations · Full text

Medicine, Hematology, Oncology +13

Biological effects and clinical significance of lenalidomide‐induced tumour flare reaction in patients with chronic lymphocytic leukaemia: <i>in vivo</i> evidence of immune activation and antitumour response

Asher Chanan‐Khan, Kasyapa S. Chitta, Noreen Ersing et al. · British Journal of Haematology · 2011 · 68 citations · Full text

Medicine, Immunology, Oncology +17

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Sikander Ailawadhi, Ryan D. Frank, Mayank Sharma et al. · Cancer · 2018 · 56 citations · Full text

Medicine, Pharmacoeconomics, Epidemiologic Methods +13

Second primary acute lymphoblastic leukemia in adults: a <scp>SEER</scp> analysis of incidence and outcomes

Abhisek Swaika, Ryan D. Frank, Dongyun Yang et al. · Cancer Medicine · 2017 · 47 citations · Full text

Medicine, Hematology, Oncology +14